| _id | dd2ac5eb2 |
| title |  |
| text | Acquisitions

Current Health Ltd.

In fiscal 2022, we acquired all of the outstanding shares of Current Health Ltd. (Current Health), a care-at-home technology platform, on November 2, 2021, for
net cash consideration of $389 million. The acquired assets included $351 million of goodwill that was assigned to our Best Buy Health reporting unit and was

deductible for income tax purposes. The acquisition is aligned with our focus in virtual care to enable people in their homes to connect seamlessly with their
health care providers and is included in our Domestic reportable segment and Services revenue category. The acquisition was accounted for using the
acquisition method of accounting for business combinations and was not material to the results of operations.

Two Peaks, LLC d/b/a Yardbird Furniture

Two Peaks, LLC d/b/a Yardbird Furniture

In fiscal 2022, we acquired all of the outstanding shares of Two Peaks, LLC d/b/a Yardbird Furniture (Yardbird), a direct-to-consumer outdoor furniture company,
on November 4, 2021, for net cash consideration of $79 million. The acquired assets included $47 million of goodwill that was assigned to our Best Buy Domestic

reporting unit and was deductible for income tax purposes. The acquisition expands our assortment in categories like outdoor living, as more and more
consumers look to make over or upgrade their outdoor living spaces. The acquisition was accounted for using the acquisition method of accounting for business
combinations and was not material to the results of our operations.

Acquisitions
 Current Health Ltd.
 In fiscal 2022 acquired all outstanding shares of Current Health Ltd. (Current Health), a care-at-home technology platform, on November 2, 2021, for
 net cash consideration of $389 million. acquired assets included $351 million of goodwill assigned to our Best Buy Health reporting unit
 deductible for income tax. acquisition aligned with focus in virtual care to people homes connect with

health care providers included in our Domestic reportable segment and Services revenue category. acquisition accounted for using
 acquisition method of accounting for business combinations not material to results of operations.
 Two Peaks, LLC d/b/a Yardbird Furniture
 In fiscal 2022, acquired all outstanding shares of Two Peaks, LLC d/b/a Yardbird Furniture (Yardbird), direct-to-consumer outdoor furniture company,

on November 4, 2021, for net cash consideration of $79 million. acquired assets included $47 million of goodwill assigned to Best Buy Domestic
 reporting unit deductible for income tax purposes. acquisition expands our assortment in categories like outdoor living, more
 consumers to upgrade outdoor living spaces. acquisition accounted for using acquisition method of accounting for business
 combinations not material to results of operations.


| _id | dd2ad4dfe |
| title |  |
| text | Usual and Customary Pricing Litigation
The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Companys retail
pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process.

Usual and Customary Pricing Litigation
 Company and certain current and former directors officers named as defendant in lawsuits allege Companys retail
 pharmacies overcharged for prescription drugs by not submitting correct usual and customary price during claims adjudication process.


| _id | dd2afc67e |
| title |  |
| text | Therachon
On July 1, 2019, we acquired all the remaining shares of Therachon, a privately-held clinical-stage biotechnology company focused on rare diseases, with assets in development for
the treatment of achondroplasia, a genetic condition and the most common form of short-limb dwarfism, for $340 million upfront, plus potential milestone payments of up to $470

million contingent on the achievement of key milestones in the development and commercialization of the lead asset. We accounted for the transaction as an asset acquisition since
the lead asset represented substantially all the fair value of the gross assets acquired. The total fair value of the consideration transferred for Therachon was $322 million, which

consisted of $317 million of cash and our previous $5 million investment in Therachon. In connection with this asset acquisition, we recorded a charge of $337 million in Research and
development expenses.

Therachon
 July 1, 2019 acquired remaining shares of Therachon, privately-held clinical-stage biotechnology company focused on rare diseases with assets in development for
 treatment of achondroplasia, genetic condition common form of short-limb dwarfism, for $340 million upfront plus potential milestone payments up to $470
 million contingent on achievement of key milestones in development and commercialization of lead asset. accounted for transaction as asset acquisition since

lead asset represented all fair value of gross assets acquired. total fair value of consideration transferred for Therachon was $322 million
 consisted of $317 million cash and previous $5 million investment in Therachon. connection asset acquisition recorded charge of $337 million in Research and
 development expenses.


| _id | dd2b17af0 |
| title |  |
| text | Walmart Inc.
Consolidated Statements of Income

Fiscal Years Ended January 31,
(Amounts in millions, except per share data)

2020

2019

2018
Revenues:

Net sales
 $
519,926
 $
510,329 $
495,761
Membership and other income

4,038

4,076
4,582
Total revenues

523,964

514,405
500,343
Costs and expenses:

Cost of sales

394,605

385,301
373,396
Operating, selling, general and administrative expenses

108,791

107,147
106,510
Operating income

20,568

21,957
20,437
Interest:

20,568

21,957
20,437
Interest:

Debt

2,262

1,975
1,978
Finance, capital lease and financing obligations

337

371
352
Interest income

(189)
(217)
(152)
Interest, net

2,410

2,129
2,178
Loss on extinguishment of debt

3,136
Other (gains) and losses

(1,958)
8,368

Income before income taxes

20,116

11,460
15,123
Provision for income taxes

4,915

4,281
4,600
Consolidated net income

15,201

7,179
10,523
Consolidated net income attributable to noncontrolling interest

(320)
(509)
(661)
Consolidated net income attributable to Walmart
 $
14,881
 $
6,670 $
9,862

Net income per common share:

Basic net income per common share attributable to Walmart
 $
5.22
 $
2.28 $
3.29
Diluted net income per common share attributable to Walmart

5.19

5.19

2.26
3.28

Weighted-average common shares outstanding:

Basic

2,850

2,929
2,995
Diluted

2,868

2,945
3,010

Dividends declared per common share
 $
2.12
 $
2.08 $
2.04
See accompanying notes.
50

Walmart Inc.
 Consolidated Statements Income
 Fiscal Years Ended January 31,
 (Amounts millions share data
 2020
 2019
 2018
 Revenues
 Net sales
 $ 519,926
 $ 510,329 $
 495,761
 Membership other income
 4,038
 4,076
 4,582
 Total revenues
 523,964
 514,405
 500,343
 Costs expenses
 Cost sales
,605
,301
 373,396
 Operating selling general administrative expenses
 108,791
 107,147
 106,510
 Operating income
 20,568
 21,957
 20,437
 Interest
 Debt
 2,262
 1,975
 1,978

20,437
 Interest
 Debt
 2,262
 1,975
 1,978
 Finance capital lease financing obligations
 337
 371
 352
 Interest income
 (189)
 (217)
 (152)
 Interest 2,410
 2,129
 2,178
 Loss extinguishment debt
 3,136
 (gains losses
 (1,958)
 8,368
 Income before income taxes
 20,116
 11,460
 15,123
 Provision income taxes
 4,281
 4,600
 Consolidated net income
 15,201
 7,179
 10,523
 Consolidated net income attributable noncontrolling interest
 (320)
 (509)
 (661)
 Consolidated net income attributable Walmart

Consolidated net income attributable Walmart
 $ 14,881
 $ 6,670 $
 Net income per common share
 net income common share attributable Walmart
 5. 22
 $ 2. 28 $
 3. 29
 Diluted net income common share attributable Walmart
 5. 19
 2. 26
 3. 28
 Weighted-average common shares
 2,850
2,929
 2,995
 Diluted
 2,868
 2,945
 3,010
 Dividends declared common share
 $ 2. 12
 $. 08
. 04
 accompanying notes.
 50


| _id | dd2af293a |
| title |  |
| text | Item 3. Legal Proceedings.
We and our subsidiaries are party to a variety of litigation, claims, legal or regulatory proceedings, inquiries and investigations.
While the results of such litigation, claims, legal or regulatory proceedings, inquiries and investigations cannot be predicted with
certainty, management believes that the final outcome of the foregoing will not have a material adverse effect on our financial

condition, results of operations or cash flows. See also Item 1. Business Regulatory Matters and Item 1A. Risk Factors.

Item 3. Legal Proceedings.
 We and our subsidiaries party to variety of litigation, claims, legal regulatory proceedings, inquiries investigations.
 results of litigation claims legal regulatory proceedings inquiries investigations be predicted with
 certainty, management believes final outcome not have material adverse effect on our financial
 condition, results operations or cash flows. See also Item 1. Business Regulatory Matters and Item 1A. Risk Factors.


| _id | dd2abfb48 |
| title |  |
| text | 129
Consolidated Statements of Operations
Years ended December 31, 2022, 2021, and 2020
2022
2021
2020
(in millions, except per share amounts)
Revenue:
Regulated
$
3,538
$
2,868
$
2,661
Non-Regulated
9,079
8,273
6,999
Total revenue
12,617
11,141
9,660
Cost of Sales:
Regulated
(3,162)
(2,448)
(2,235)
Non-Regulated
(6,907)
(5,982)
(4,732)
Total cost of sales
(10,069)
(8,430)
(6,967)
Operating margin
2,548
2,711
2,693
General and administrative expenses
(207)
(166)
(165)
Interest expense
(1,117)

(207)
(166)
(165)
Interest expense
(1,117)
(911)
(1,038)
Interest income
389
298
268
Loss on extinguishment of debt
(15)
(78)
(186)
Other expense
(68)
(60)
(53)
Other income
102
410
75
Loss on disposal and sale of business interests
(9)
(1,683)
(95)
Goodwill impairment expense
(777)

Asset impairment expense
(763)
(1,575)
(864)
Foreign currency transaction gains (losses)
(77)
(10)
55
Other non-operating expense
(175)

(202)

55
Other non-operating expense
(175)

(202)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE TAXES AND EQUITY IN EARNINGS OF AFFILIATES
(169)
(1,064)
488
Income tax benefit (expense)
(265)
133
(216)
Net equity in losses of affiliates
(71)
(24)
(123)
INCOME (LOSS) FROM CONTINUING OPERATIONS
(505)
(955)
149
Gain from disposal of discontinued businesses, net of income tax expense of $0, $1, and $0, respectively

4
3
NET INCOME (LOSS)
(505)
(951)
152

4
3
NET INCOME (LOSS)
(505)
(951)
152
Less: Net loss (income) attributable to noncontrolling interests and redeemable stock of subsidiaries
(41)
542
(106)
NET INCOME (LOSS) ATTRIBUTABLE TO THE AES CORPORATION
$
(546)
$
(409)
$
46
AMOUNTS ATTRIBUTABLE TO THE AES CORPORATION COMMON STOCKHOLDERS:
Income (loss) from continuing operations, net of tax
$
(546)
$
(413)
$
43
Income from discontinued operations, net of tax

4
3
NET INCOME (LOSS) ATTRIBUTABLE TO THE AES CORPORATION
$
(546)
$
(409)
$
46

$
(546)
$
(409)
$
46
BASIC EARNINGS PER SHARE:
Income (loss) from continuing operations attributable to The AES Corporation common stockholders, net of tax
$
(0.82)
$
(0.62)
$
0.06
Income from discontinued operations attributable to The AES Corporation common stockholders, net of tax

0.01
0.01
NET INCOME (LOSS) ATTRIBUTABLE TO THE AES CORPORATION COMMON STOCKHOLDERS
$
(0.82)
$
(0.61)
$
0.07
DILUTED EARNINGS PER SHARE:

$
(0.61)
$
0.07
DILUTED EARNINGS PER SHARE:
Income (loss) from continuing operations attributable to The AES Corporation common stockholders, net of tax
$
(0.82)
$
(0.62)
$
0.06
Income from discontinued operations attributable to The AES Corporation common stockholders, net of tax

0.01
0.01
NET INCOME (LOSS) ATTRIBUTABLE TO THE AES CORPORATION COMMON STOCKHOLDERS
$
(0.82)
$
(0.61)
$
0.07
See Accompanying Notes to Consolidated Financial Statements.

Consolidated Statements Operations
 ended December 31, 2022 2021 2020
 millions share amounts
 Revenue
 Regulated
 $
 3,538
 2,868
 $ 2,661
 Non-Regulated
 9,079
 8,273
 6,999
 Total revenue
 12,617
 11,141
 9,660
 Cost Sales
 Regulated
 (3,162)
 (2,448)
 (2,235)
 Non-Regulated
 (6,907)
 (5,982)
 (4,732)
 Total cost sales
 (10,069)
 (8,430)
 (6,967)
 Operating margin
 2,548
 2,711
 2,693
 General administrative expenses
 (207)
 (166)
 (165)
 Interest expense
 (1,117)
 (911)
 (1,038)
 Interest income

(1,117)
 (911)
 (1,038)
 Interest income
 268
 Loss extinguishment debt
 (15)
 (78)
 (186)
 Other expense
 (68)
 (60) (53)
 102 410
 75 Loss disposal sale business interests
 (1,683)
 Goodwill impairment expense
 (777)
 Asset impairment expense
 (763)
 (1,575)
 (864)
 Foreign currency transaction gains (losses
 (77)
 55 non expense
 (175)
 (202)
 INCOME (LOSS) FROM OPERATIONS BEFORE TAXES EQUITY AFFILIATES
 (169)
 (1,064)
 488 Income tax benefit (expense
 (265)
 133
 (216)
 Net equity losses affiliates

(265)
 133
 (216)
 Net equity losses affiliates
 (71)
 (24)
 (123)
 INCOME (LOSS) FROM OPERATIONS
 (505)
 (955)
 149
 Gain disposal discontinued businesses income tax expense $0 $1 $0,
 3 INCOME (LOSS)
 (505)
 (951)
 152Net loss (income noncontrolling interests redeemable stock subsidiaries
 (41)
 542
 (106)
 NET INCOME (LOSS AES CORPORATION
 $
 (546)
 $
 (409)
 $
 46
 AMOUNTS AES CORPORATION COMMON STOCKHOLDERS:
 Income (loss) from continuing operations net of tax
 $
 (546)
 $
 (413)
 43

$
 (546)
 $
 (413)
 43
 Income discontinued operations net of tax
 4
 3
 NET INCOME (LOSS) AES CORPORATION
 $
 (546)
 $
 (409)
 $
 46
 BASIC EARNINGS PER SHARE:
 Income (loss) from continuing operations AES Corporation common stockholders net of tax
 $
 (0. 82)
 $
 (0. 62)
 0. 06
 Income from discontinued operations AES Corporation common stockholders net of tax
. 01
.
 NET INCOME (LOSS) AES CORPORATION COMMON STOCKHOLDERS
 $
 (0. 82)
 $
 (0. 61)
 $
 0. 07
 DILUTED EARNINGS PER SHARE:

(0. 61)
 $
 0. 07
 DILUTED EARNINGS PER SHARE:
 Income (loss) from continuing operations AES Corporation common stockholders net of tax
 $
 (0. 82)
. 62)
.
 Income from discontinued operations AES Corporation common stockholders net of tax
 0. 01
.
 NET INCOME (LOSS) AES CORPORATION COMMON STOCKHOLDERS
 (0. 82)
 $
 (0. 61)
 $
 0. 07
 Accompanying Notes to Consolidated Financial Statements.


| _id | dd2abccf4 |
| title |  |
| text | This marked the 65th consecutive
year of dividend increases for 3M.

marked 65th consecutive
 year dividend increases for 3M.


| _id | dd2acce74 |
| title |  |
| text | SQUARE, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
Year Ended December 31,
2020
2019
2018
Revenue:
Transaction-basedrevenue
$
3,294,978
$
3,081,074
$
2,471,451
Subscriptionandservices-basedrevenue
1,539,403
1,031,456
591,706
Hardwarerevenue
91,654
84,505
68,503
Bitcoinrevenue
4,571,543
516,465
166,517
Totalnetrevenue
9,497,578
4,713,500
3,298,177
Costofrevenue:
Transaction-basedcosts
1,911,848
1,937,971
1,558,562
Subscriptionandservices-basedcosts
222,712
234,270

222,712
234,270
169,884
Hardwarecosts
143,901
136,385
94,114
Bitcoincosts
4,474,534
508,239
164,827
Amortizationofacquiredtechnology
11,174
6,950
7,090
Totalcostofrevenue
6,764,169
2,823,815
1,994,477
Grossprofit
2,733,409
1,889,685
1,303,700
Operatingexpenses:
Productdevelopment
881,826
670,606
497,479
Salesandmarketing
1,109,670
624,832
411,151
Generalandadministrative
579,203
436,250
339,245
Transactionandloanlosses
177,670
126,959
88,077
Amortizationofacquiredcustomerassets
3,855
4,481
4,362

3,855
4,481
4,362
Totaloperatingexpenses
2,752,224
1,863,128
1,340,314
Operatingincome(loss)
(18,815)
26,557
(36,614)
Gainonsaleofassetgroup

(373,445)

Interestexpense,net
56,943
21,516
17,982
Otherexpense(income),net
(291,725)
273
(18,469)
Income(loss)beforeincometax
215,967
378,213
(36,127)
Provisionforincometaxes
2,862
2,767
2,326
Netincome(loss)
$
213,105
$
375,446
$
(38,453)
Netincome(loss)pershare:
Basic
$
0.48
$
0.88
$
(0.09)
Diluted
$
0.44
$
0.81
$
(0.09)
Weighted-averagesharesusedtocomputenetincome(loss)pershare:
Basic
443,126
424,999
405,731
Diluted
482,167
466,076
405,731
Seeaccompanyingnotestoconsolidatedfinancialstatements.
85

.
 CONSOLIDATED STATEMENTS OPERATIONS
 share
 December 31,
 Transaction-basedrevenue
 3,294,978
 3,081,074
 2,471,451
 Subscriptionandservices-basedrevenue
 1,539,403
 1,031,456
 591,706
 Hardwarerevenue
 91,654
 84,505
 68,503
 Bitcoinrevenue
 4,571,543
 516,465
 166,517
 Totalnetrevenue
 9,497,578
,500
 3,298,177
 Costofrevenue
 Transaction-basedcosts
 1,911,848
 1,937,971
 1,558,562
 Subscriptionandservices-basedcosts
 222,712
 234,270
 169,884
 Hardwarecosts 143,901
 136,385
 94,114
 Bitcoincosts

136,385
 94,114
 Bitcoincosts
 4,474,534
 508,239
 164,827
 Amortizationofacquiredtechnology
 11,174 6,950
 7,090
 Totalcostofrevenue
 6,764,169
 2,823,815
 1,994,477
 Grossprofit
 2,733,409
 1,889,685
 1,303,700
 Operatingexpenses
 Productdevelopment
 881,826
 670,606
,479
 1,109,670
 624,832
 411,151
,203
,250
,245
 Transactionandloanlosses 177,670
 126,959
 88,077
 Amortizationofacquiredcustomerassets
 3,855
 4,481
 4,362
 Totaloperatingexpenses
 2,752,224
 1,863,128
 1,340,314
 Operatingincome(loss

1,863,128
 1,340,314
 Operatingincome(loss
 (18 26,557 (373,445) 56,943
 21,516 17,982
 Otherexpense (291,725)
273
 (18,469)
 Income(loss)beforeincometax
 215,967
,213
 (36,127)
 Provisionforincometaxes
 2,862
 2,767
 2,326
 Netincome(loss)
 213,105
 375,446
 $ (38,453)
 Netincome(loss)pershare:
. 48
. 88
 (0. 09)
 Diluted
. 44
. 81
 (0. 09)
 Weighted-averagesharesusedtocomputenetincome(loss)pershare:
,126
 424,999
 405,731
 Diluted 482,167
 466,076
 405,731

405,731
 Diluted 482,167
 466,076
 405,731
 Seeaccompanyingnotestoconsolidatedfinancialstatements.
 85


| _id | dd2ae6e5a |
| title |  |
| text | Las Vegas Strip Resorts

Net revenues of $8.4 billion in the current year compared to $4.7 billion in the prior year, an
increase of 77%;

Las Vegas Strip Resorts
 Net revenues $8. 4 billion current year compared to $4. 7 billion prior year,
 increase of 77%;


| _id | dd2ac147a |
| title |  |
| text | Amcor plc and Subsidiaries
Consolidated Statements of Income
($ in millions, except per share data)
For the years ended June 30,
2023
2022
2021
Net sales
$
14,694
$
14,544
$
12,861
Cost of sales
(11,969)
(11,724)
(10,129)
Gross profit
2,725
2,820
2,732

Amcor plc Subsidiaries
 Consolidated Statements Income
$ millions share data
 ended June 30
 2023
 2022
 2021
 sales
 $
 14,694
 $
 14,544
 $
 12,861
 Cost sales
 (11,969)
 (11,724)
 (10,129)
 profit
 2,725
 2,820
 2,732


| _id | dd2b08bc2 |
| title |  |
| text | Pension and postretirement health care and life insurance benefits earned during the year, as well as interest on projected benefit obligations,
are accrued.

Pension postretirement health care life insurance benefits earned during year, interest on projected benefit obligations,
 are accrued.


| _id | dd2b0b110 |
| title |  |
| text | Consolidated Balance Sheets
Verizon Communications Inc. and Subsidiaries
(dollars in millions, except per share amounts)
At December 31,
2022
2021
Assets
Current assets
Cash and cash equivalents
$
2,605
$
2,921
Accounts receivable

25,332

24,742
Less Allowance for credit losses

826

896
Accounts receivable, net

24,506

23,846
Inventories

2,388

3,055
Prepaid expenses and other

8,358

6,906
Total current assets

37,857

36,728
Property, plant and equipment

307,689

Property, plant and equipment

307,689

289,897
Less Accumulated depreciation

200,255

190,201
Property, plant and equipment, net

107,434

99,696
Investments in unconsolidated businesses

1,071

1,061
Wireless licenses

149,796

147,619
Goodwill

28,671

28,603
Other intangible assets, net

11,461

11,677
Operating lease right-of-use assets

26,130

27,883
Other assets

17,260

13,329
Total assets
$
379,680
$
366,596
Liabilities and Equity
Current liabilities

Liabilities and Equity
Current liabilities
Debt maturing within one year
$
9,963
$
7,443
Accounts payable and accrued liabilities

23,977

24,833
Current operating lease liabilities

4,134

3,859
Other current liabilities

12,097

11,025
Total current liabilities

50,171

47,160

Consolidated Balance Sheets
 Verizon Communications Inc. Subsidiaries
 (dollars millions except share amounts
 December 31,
 2022
 2021 Assets Current assets Cash cash equivalents
 $ 2,605
 $ 2,921
 Accounts receivable
 25,332
 24,742
 Allowance credit losses
 826 896 Accounts receivable
 24,506
 23,846
 Inventories
 2,388
 3,055
 Prepaid expenses other
 8,358
 Total current assets
 37,857
 36,728
 Property plant equipment
 307,689
 289,897
 Accumulated depreciation
 200,255
 190,201

Accumulated depreciation
 200,255
 190,201
 Property plant equipment net
 107,434
 99,696
 Investments unconsolidated businesses
 1,071 1,061 Wireless licenses
 149,796
 147,619
 Goodwill
 28,671
 28,603
 Other intangible assets
 11,461
 11,677 Operating lease right-of-use assets
 26,130
 27,883
 Other assets
 17,260
 13,329
 Total assets
,680
 366,596
 Liabilities Equity
 Current liabilities Debt maturing within one year
 7,443
 Accounts payable accrued liabilities
 23,977
 24,833

23,977
 24,833
 Current operating lease liabilities
 4,134
 3,859
 Other current liabilities
 12,097
 11,025
 Total current liabilities
 50,171
 47,160


| _id | dd2abca56 |
| title |  |
| text | Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, Par Value $.01 Per Share
MMM
New York Stock Exchange
MMM
Chicago Stock Exchange, Inc.
1.500% Notes due 2026
MMM26
New York Stock Exchange
1.750% Notes due 2030
MMM30
New York Stock Exchange
1.500% Notes due 2031
MMM31
New York Stock Exchange

Title class
 Trading Symbol(s
 Name exchange registered
 Common Stock Value $. 01 Per Share
 MMM
 New York Stock Exchange
 Chicago Stock Exchange.
. 500% Notes due 2026
 MMM26
 New York Stock Exchange
. 750% Notes 2030
 MMM30
 New York Stock Exchange
. 500% Notes 2031
 MMM31
 New York Stock Exchange


| _id | dd2ac1222 |
| title |  |
| text | Today, we are a global leader in developing and producing responsible
packaging for food, beverage, pharmaceutical, medical, home and personal-care, and other products

Today, we are global leader in developing producing responsible
 packaging for food beverage pharmaceutical medical home personal-care other products


| _id | dd2abfada |
| title |  |
| text | 128
Consolidated Balance Sheets
December 31, 2022 and 2021
2022
2021
(in millions, except share and per share data)
ASSETS
CURRENT ASSETS
Cash and cash equivalents
$
1,374
$
943
Restricted cash
536
304
Short-term investments
730
232
Accounts receivable, net of allowance for doubtful accounts of $5 and $5, respectively
1,799
1,418
Inventory
1,055
604
Prepaid expenses
98
142
Other current assets, net of CECL allowance of $2 and $0, respectively
1,533
897
Current held-for-sale assets
518
816

897
Current held-for-sale assets
518
816
Total current assets
7,643
5,356
NONCURRENT ASSETS
Property, Plant and Equipment:
Land
470
426
Electric generation, distribution assets and other
26,599
25,552
Accumulated depreciation
(8,651)
(8,486)
Construction in progress
4,621
2,414
Property, plant and equipment, net
23,039
19,906
Other Assets:
Investments in and advances to affiliates
952
1,080
Debt service reserves and other deposits
177
237
Goodwill
362
1,177

177
237
Goodwill
362
1,177
Other intangible assets, net of accumulated amortization of $434 and $385, respectively
1,841
1,450
Deferred income taxes
319
409
Loan receivable, net of allowance of $26
1,051

Other noncurrent assets, net of allowance of $51 and $23, respectively
2,979
2,188
Noncurrent held-for-sale assets

1,160
Total other assets
7,681
7,701
TOTAL ASSETS
$
38,363
$
32,963
LIABILITIES AND EQUITY
CURRENT LIABILITIES
Accounts payable
$
1,730
$
1,153
Accrued interest
249
182

$
1,730
$
1,153
Accrued interest
249
182
Accrued non-income taxes
249
266
Accrued and other liabilities
2,151
1,205
Non-recourse debt, including $416 and $302, respectively, related to variable interest entities
1,758
1,367
Current held-for-sale liabilities
354
559
Total current liabilities
6,491
4,732
NONCURRENT LIABILITIES
Recourse debt
3,894
3,729
Non-recourse debt, including $2,295 and $2,223, respectively, related to variable interest entities
17,846
13,603
Deferred income taxes

17,846
13,603
Deferred income taxes
1,139
977
Other noncurrent liabilities
3,168
3,358
Noncurrent held-for-sale liabilities

740
Total noncurrent liabilities
26,047
22,407
Commitments and Contingencies (see Notes 12 and 13)
Redeemable stock of subsidiaries
1,321
1,257
EQUITY
THE AES CORPORATION STOCKHOLDERS EQUITY
Preferred stock (without par value, 50,000,000 shares authorized; 1,043,050 issued and outstanding at December 31, 2022 and
December 31, 2021)
838
838

December 31, 2021)
838
838
Common stock ($0.01 par value, 1,200,000,000 shares authorized; 818,790,001 issued and 668,743,464 outstanding at December
31, 2022 and 818,717,043 issued and 666,793,625 outstanding at December 31, 2021)
8
8
Additional paid-in capital
6,688
7,106
Accumulated deficit
(1,635)
(1,089)
Accumulated other comprehensive loss
(1,640)
(2,220)
Treasury stock, at cost (150,046,537 and 151,923,418 shares at December 31, 2022 and December 31, 2021, respectively)
(1,822)
(1,845)

(1,822)
(1,845)
Total AES Corporation stockholders equity
2,437
2,798
NONCONTROLLING INTERESTS
2,067
1,769
Total equity
4,504
4,567
TOTAL LIABILITIES AND EQUITY
$
38,363
$
32,963
See Accompanying Notes to Consolidated Financial Statements.

128
 Consolidated Balance Sheets
 December 31, 2022 2021
 millions except share share data
 CURRENT ASSETS
 Cash cash equivalents
 $
 1,374
 943
 Restricted cash
 536
 304
 Short-term investments
 730
 232
 Accounts receivable allowance doubtful accounts $5 $5
 1,799
 1,418
 Inventory
 1,055
 604
 Prepaid expenses
 98
 142
 Other current assets CECL allowance $2 $0
 1,533
 897
 Current held-for-sale assets
 518
 816
 Total current assets
 5,356
 NONCURRENT
 Property Plant Equipment
 Land
 470
 426

Property Plant Equipment
 Land
 470
 426
 Electric generation distribution assets
 26,599
 25,552
 Accumulated depreciation
 (8,651)
 (8,486)
 Construction progress
 4,621 2,414
 Property plant equipment net
 23,039
 19,906
 Other Assets
 Investments advances affiliates
 952
 1,080
 Debt service reserves deposits
 177
 237
 Goodwill
 362
 1,177
 Other intangible assets accumulated amortization $434 $385
 1,841
 1,450
 Deferred income taxes
 319
 409
 Loan receivable allowance $26
 1,051

319
 409
 Loan receivable allowance $26
 1,051
 Other noncurrent assets net allowance $51 $23
 2,979
 2,188
 Noncurrent held-for-sale assets
 1,160
 Total other assets
 7,681
 7,701
 TOTAL
 $
 38,363
 32,963
 LIABILITIES EQUITY
 CURRENT LIABILITIES
 Accounts payable
 $
 1,730
 1,153
 Accrued interest
 249
 182
 Accrued non-income taxes
 249
 266
 Accrued other liabilities
 2,151
 1,205
Non debt $416 $302 variable interest entities
 1,758
 1,367
 Current held-for-sale liabilities
 354
 559

Current held-for-sale liabilities
 354
 559
 Total current liabilities
 6,491
 4,732
 NONCURRENT LIABILITIES
 Recourse debt
 3,894
 3,729
 Non-recourse debt $2,295 $2,223 variable interest entities
 17,846
 13,603
 Deferred income taxes
 1,139
 977
 Other noncurrent liabilities
 3,168
 3,358
 Noncurrent held-for-sale liabilities
 740
 Total noncurrent liabilities
 26,047
 22,407
 Commitments Contingencies Notes 12 13
 Redeemable stock subsidiaries
 1,321
 1,257
 AES CORPORATION EQUITY

1,321
 1,257
 AES CORPORATION EQUITY
 Preferred stock 50,000,000 authorized 1,043,050 issued outstanding December 31, 2022
 31, 2021
 838
 Common stock ($0. 01 par value 1,200,000,000 shares authorized 818,790,001 issued 668,743,464 outstanding December
 31, 2022 818,717,043 666,793,625 December 31, 2021
 8
 Additional paid-in capital
 6,688
 7,106
 Accumulated deficit
 (1,635)
 (1,089)
 comprehensive loss
 (1,640)
 (2,220)
 Treasury stock (150,046,537 151,923,418 shares December 31, 2022 31, 2021

(1,822)
 (1,845)
 Total AES Corporation stockholders equity
 2,437
 2,798
 NONCONTROLLING INTERESTS
 2,067
 1,769
 Total equity
 4,504
 4,567
 TOTAL LIABILITIES EQUITY
 38,363
 32,963
 Accompanying Notes Consolidated Financial Statements.


| _id | dd2ad4e6c |
| title |  |
| text | The Company is facing multiple lawsuits, including by state Attorneys General, governmental subdivisions and several putative class actions, regarding drug
pricing and its rebate arrangements with drug manufacturers. These complaints, brought by a number of different types of plaintiffs under a variety of legal
theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products.

Company facing multiple lawsuits including by state Attorneys General, governmental subdivisions putative class actions, regarding drug
 pricing rebate arrangements with drug manufacturers. complaints, brought by different types plaintiffs under variety of legal
 theories, allege rebate agreements between drug manufacturers and PBMs caused inflated prices for certain drug products.


| _id | dd2aec936 |
| title |  |
| text | Table of Contents
NIKE, Inc. Consolidated Statements of Income

Year Ended May 31,
(In millions, except per share data)

2018

2017

2016
Revenues
 $
36,397
 $
34,350 $
32,376
Cost of sales

20,441

19,038
17,405
Gross profit

15,956

15,312
14,971
Demand creation expense

3,577

3,341
3,278
Operating overhead expense

7,934

7,222
7,191
Total selling and administrative expense

11,511

10,563
10,469
Interest expense (income), net

54

59
19
Other expense (income), net

66

54

59
19
Other expense (income), net

66

(196)
(140)
Income before income taxes

4,325

4,886
4,623
Income tax expense

2,392

646
863
NET INCOME
 $
1,933
 $
4,240 $
3,760

Earnings per common share:

Basic
 $
1.19
 $
2.56 $
2.21
Diluted
 $
1.17
 $
2.51 $
2.16

Dividends declared per common share
 $
0.78
 $
0.70 $
0.62
The accompanying Notes to the Consolidated Financial Statements are an integral part of this statement.
44

Table Contents
 NIKE Inc. Consolidated Statements Income
 Year Ended May 31,
 millions share data
 2018
 2017
 2016
 Revenues
 $
 36,397
 $ 34,350 $
 32,376
 Cost sales
 20,441
 19,038
 17,405
 Gross profit
 15,956
 15,312
 14,971
 Demand creation expense
 3,577
 3,341
 3,278
 Operating overhead expense
 7,222
 7,191
 Total selling administrative expense
 11,511
 10,563
 10,469
 Interest expense (income),
 54
 59
 19
 Other expense (income),
 66
 (196)
 (140)
 Income income taxes
 4,325
 4,886

(196)
 (140)
 Income income taxes
 4,325
 4,886
 Income tax expense
 2,392
 INCOME
 $ 1,933
 $ 4,240 $
 3,760
 Earnings common share
 Basic $ 1. 19
 $
 2. 56 $
 2. 21
 Diluted
 $ 1. 17
 $ 2. 51 $
 2. 16
 Dividends declared common share
 $ 0. 78
 $
 0. 70 $
. 62
 accompanying Notes Consolidated Financial Statements integral part statement.
 44


| _id | dd2addc24 |
| title |  |
| text | The Kraft Heinz Company
Consolidated Statements of Income
(in millions, except per share data)

December 28, 2019 December 29, 2018 December 30, 2017
Net sales
$
24,977
 $
26,268 $
26,076
Cost of products sold
16,830

17,347
17,043
Gross profit
8,147

8,921
9,033
Selling, general and administrative expenses, excluding impairment losses
3,178

3,190
2,927
Goodwill impairment losses
1,197

7,008

Intangible asset impairment losses
702

8,928
49
Selling, general and administrative expenses
5,077

19,126
2,976
Operating income/(loss)
3,070

(10,205)
6,057
Interest expense
1,361

1,284
1,234
Other expense/(income)
(952)
(168)
(627)
Income/(loss) before income taxes
2,661

(11,321)
5,450
Provision for/(benefit from) income taxes
728

(1,067)
(5,482)
Net income/(loss)
1,933

(10,254)
10,932
Net income/(loss) attributable to noncontrolling interest
(2)
(62)
(9)

(2)
(62)
(9)
Net income/(loss) attributable to common shareholders
$
1,935
 $
(10,192) $
10,941
Per share data applicable to common shareholders:

Basic earnings/(loss)
$
1.59
 $
(8.36) $
8.98
Diluted earnings/(loss)
1.58

(8.36)
8.91
See accompanying notes to the consolidated financial statements.
45

Kraft Heinz Company
 Consolidated Statements Income
 millions except share data
 December 28, 2019 29, 2018 30, 2017
 Net sales
 $
 24,977
 26,268 $
 26,076
 Cost products sold
 16,830
 17,347
 17,043
 Gross profit
 8,147
 9,033
 Selling general administrative expenses excluding impairment losses
 3,178
 3,190
 2,927
 Goodwill impairment losses
 1,197
 7,008
 Intangible impairment losses
 702
 49
 Selling general administrative expenses
 5,077
 19,126
 2,976
 Operating income/(loss)
 3,070
 (10,205)

2,976
 Operating income/(loss)
 3,070
 (10,205)
 Interest expense
 1,361
 1,284
 1,234
 Other expense/(income
 (952)
 (168)
 (627)
 Income/(loss) before income taxes
 2,661
 (11,321)
 5,450
 Provision(benefit income taxes
 728
 (1,067)
 (5,482)
 Net income/(loss
 1,933
 (10,254)
 10,932
 Net income(loss noncontrolling interest
 (62) Net income common shareholders
 $
 1,935
 (10,192)
 10,941
 share data common shareholders
 Basic earnings/(loss)
 $ 1. 59
 $ (8. 36)
 8. 98
 Diluted earnings/(loss)
 1. 58

$ (8. 36)
 8. 98
 Diluted earnings/(loss)
 1. 58
 (8. 36
.
 accompanying notes consolidated financial statements.
 45


| _id | dd2ad9520 |
| title |  |
| text | Analysis of Consolidated Earnings Before Provision for Taxes on Income
Consolidated earnings before provision for taxes on income was $21.7 billion and $22.8 billion for the years 2022 and 2021, respectively. As a percent to
sales, consolidated earnings before provision for taxes on income was 22.9% and 24.3%, in 2022 and 2021, respectively.
(Dollars in billions. Percentages in chart are as a percent to total sales)
Cost of Products Sold and Selling, Marketing and Administrative Expenses:

(Dollars in billions. Percentages in chart are as a percent to total sales)
Cost of products sold increased as a percent to sales driven by:

One-time COVID-19 vaccine manufacturing exit related costs

Currency impacts in the Pharmaceutical segment

Commodity inflation in the MedTech and Consumer Health segments
partially offset by

Supply chain benefits in the Consumer Health segment
The intangible asset amortization expense included in cost of products sold was $4.3 billion and $4.7 billion for the fiscal years 2022 and 2021,
respectively.

Analysis Consolidated Earnings Before Provision Taxes on Income
 Consolidated earnings before provision taxes was $21. 7 billion and $22. 8 billion years 2022 2021 respectively. percent to
 sales consolidated earnings before provision taxes was 22. 9% and 24. 3%, in 2022 2021 respectively.
 (Dollars in billions. Percentages chart percent to total sales)
 Cost of Products Sold Selling, Marketing Administrative Expenses:
 (Dollars billions. Percentages chart percent to total sales

Cost of products sold increased percent to sales driven by
 One-time COVID-19 vaccine manufacturing exit related costs
 Currency impacts in Pharmaceutical segment
 Commodity inflation MedTech Consumer Health segments
 partially offset by
 Supply chain benefits in Consumer Health segment
 intangible asset amortization expense in cost of products sold was $4. 3 billion and $4. 7 billion for fiscal years 2022 2021
.


| _id | dd2af0432 |
| title |  |
| text | PayPal Holdings, Inc.
CONSOLIDATED BALANCE SHEETS

As of December 31,
2022
2021

(In millions, except par value)
ASSETS
Current assets:
Cash and cash equivalents
$
7,776
$
5,197
Short-term investments
3,092
4,303
Accounts receivable, net
963
800
Loans and interest receivable, net of allowances of $598 and $491 as of December 31, 2022 and 2021,
respectively
7,431
4,846
Funds receivable and customer accounts
36,357
36,141
Prepaid expenses and other current assets
1,898
1,287
Total current assets

1,898
1,287
Total current assets
57,517
52,574
Long-term investments
5,018
6,797
Property and equipment, net
1,730
1,909
Goodwill
11,209
11,454
Intangible assets, net
788
1,332
Other assets
2,455
1,737
Total assets
$
78,717
$
75,803
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable
$
126
$
197
Funds payable and amounts due to customers
40,107
38,841
Accrued expenses and other current liabilities
4,055
3,755
Income taxes payable
813
236
Total current liabilities
45,101

813
236
Total current liabilities
45,101
43,029
Deferred tax liability and other long-term liabilities
2,925
2,998
Long-term debt
10,417
8,049
Total liabilities
58,443
54,076
Commitments and contingencies (Note 13)
Equity:
Common stock, $0.0001 par value; 4,000 shares authorized; 1,136 and 1,168 shares outstanding as of
December 31, 2022 and 2021, respectively

Preferred stock, $0.0001 par value; 100 shares authorized, unissued

Treasury stock at cost, 173 and 132 shares as of December 31, 2022 and 2021, respectively
(16,079)
(11,880)
Additional paid-in-capital
18,327
17,208
Retained earnings
18,954
16,535
Accumulated other comprehensive income (loss)
(928)
(136)
Total equity
20,274
21,727
Total liabilities and equity
$
78,717
$
75,803
The accompanying notes are an integral part of these consolidated financial statements.
6

PayPal Holdings Inc.
 CONSOLIDATED BALANCE
 December 31,
 2022
 2021
 millions except par value
 Current assets
 Cash equivalents
 $
 7,776
 5,197
 Short-term investments
 3,092
 4,303
 Accounts receivable net
 963
 800
 Loans interest receivable $598 $491 December 31, 2022 2021
 7,431
 Funds receivable customer accounts
 36,357
 36,141
 Prepaid expenses current assets
 1,898
 1,287
 Total current assets
 57,517
 52,574
 Long-term investments
 5,018
 Property equipment net
 1,730
 1,909
 Goodwill
 11,209

1,730
 1,909
 Goodwill
 11,209
 11,454
 Intangible assets net
 788
 1,332
 Other assets
 2,455
 1,737
 Total assets
 $
 78,717
 75,803
 LIABILITIES EQUITY
 Current liabilities
 Accounts payable
 $
 126
 $
 197
 Funds payable amounts due customers
 40,107
 38,841
 Accrued expenses current liabilities
 4,055
 3,755
 Income taxes payable
 813
 236
 Total current liabilities
 45,101
 43,029
 Deferred tax liability long-term liabilities
 2,925
 2,998
 Long-term debt
 10,417
 Total liabilities
 58,443
 54,076

10,417
 Total liabilities
 58,443
 54,076
 Commitments contingencies (Note 13
 Equity
 Common stock $0. 0001 par value shares authorized 1,136 1,168 shares outstanding
 December 31, 2022 2021
 Preferred stock $0. 0001 par value 100 shares authorized unissued
 Treasury stock cost 173 132 shares December 31, 2022 2021
 (16,079)
 (11,880)
Additional paid-in-capital
 18,327
 17,208
 Retained earnings
 18,954
 16,535
 Accumulated comprehensive income (loss
 (928)
 Total equity
 20,274
 21,727

(928)
 Total equity
 20,274
 21,727
 liabilities equity
 $
 78,717
 $
 75,803
 accompanying notes consolidated financial statements.
 6


| _id | dd2ad469c |
| title |  |
| text | Consolidated Balance Sheets
At December 31,
In millions, except per share amounts
2022
2021
Assets:

Cash and cash equivalents
$
12,945 $
9,408
Investments
2,778
3,117
Accounts receivable, net
27,276
24,431
Inventories
19,090
17,760
Assets held for sale
908

Other current assets
2,685
5,292
Total current assets
65,682
60,008
Long-term investments
21,096
23,025
Property and equipment, net
12,873
12,896
Operating lease right-of-use assets
17,872
19,122
Goodwill
78,150
79,121

17,872
19,122
Goodwill
78,150
79,121
Intangible assets, net
24,754
29,026
Separate accounts assets
3,228
5,087
Other assets
4,620
4,714
Total assets
$
228,275 $
232,999

Consolidated Balance Sheets
 December 31,
 millions share amounts
 2022
 2021
 Assets
 Cash equivalents
 12,945
 9,408
 Investments
 2,778
 3,117
 Accounts receivable
 27,276
 24,431
 Inventories
 19,090
 17,760
 Assets sale
 908
 current assets
 2,685
 5,292
 Total assets
 65,682
 60,008
 Long-term investments
 21,096
 23,025
 Property equipment
 12,873
 12,896
 Operating lease right-of-use assets
 17,872
 19,122
 Goodwill
 78,150
 79,121
 Intangible assets
 24,754
 29,026
 Separate accounts
 3,228

24,754
 29,026
 Separate accounts
 3,228
 5,087
 Other assets
 Total assets
 228,275
,999


| _id | dd2ad061e |
| title |  |
| text | THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
December 31,
2017

2016
(In millions except par value)

ASSETS

CURRENT ASSETS

Cash and cash equivalents
$
6,006
 $
8,555
Short-term investments
9,352

9,595
TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
15,358

18,150
Marketable securities
5,317

4,051
Trade accounts receivable, less allowances of $477 and $466, respectively
3,667

3,856
Inventories
2,655

2,675
Prepaid expenses and other assets
2,000

2,481

Prepaid expenses and other assets
2,000

2,481
Assets held for sale
219

2,797
Assets held for sale discontinued operations
7,329

TOTAL CURRENT ASSETS
36,545

34,010
EQUITY METHOD INVESTMENTS
20,856

16,260
OTHER INVESTMENTS
1,096

989
OTHER ASSETS
4,560

4,248
PROPERTY, PLANT AND EQUIPMENT net
8,203

10,635
TRADEMARKS WITH INDEFINITE LIVES
6,729

6,097
BOTTLERS' FRANCHISE RIGHTS WITH INDEFINITE LIVES
138

3,676
GOODWILL
9,401

10,629
OTHER INTANGIBLE ASSETS
368

726
TOTAL ASSETS
$
87,896
 $
87,270
LIABILITIES AND EQUITY

CURRENT LIABILITIES

Accounts payable and accrued expenses
$
8,748
 $
9,490

$
8,748
 $
9,490
Loans and notes payable
13,205

12,498
Current maturities of long-term debt
3,298

3,527
Accrued income taxes
410

307
Liabilities held for sale
37

710
 Liabilities held for sale discontinued operations
1,496

TOTAL CURRENT LIABILITIES
27,194

26,532
LONG-TERM DEBT
31,182

29,684
OTHER LIABILITIES
8,021

4,081
DEFERRED INCOME TAXES
2,522

3,753
THE COCA-COLA COMPANY SHAREOWNERS' EQUITY

 Common stock, $0.25 par value; Authorized 11,200 shares;
 Issued 7,040 and 7,040 shares, respectively
1,760

1,760
Capital surplus
15,864

14,993
Reinvested earnings
60,430

65,502
Accumulated other comprehensive income (loss)
(10,305)
(11,205)
Treasury stock, at cost 2,781 and 2,752 shares, respectively
(50,677)

(50,677)
(47,988)
EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY
17,072

23,062
EQUITY ATTRIBUTABLE TO NONCONTROLLING INTERESTS
1,905

158
TOTAL EQUITY
18,977

23,220
TOTAL LIABILITIES AND EQUITY
$
87,896
 $
87,270
Refer to Notes to Consolidated Financial Statements.
74

COCA-COLA COMPANY SUBSIDIARIES
 CONSOLIDATED BALANCE SHEETS
 December 31,
 2017
 2016 millions value ASSETS CURRENT ASSETS
 Cash cash equivalents
 6,006
 8,555
 Short-term investments
 9,352
 9,595
 TOTAL CASH CASH EQUIVALENTS SHORT-TERM INVESTMENTS
 15,358
 18,150
 Marketable securities
 5,317
 4,051
 Trade accounts receivable allowances $477 $466
 3,667
 3,856
 Inventories
 2,655
 2,675
 Prepaid expenses assets
 2,000 2,481
 Assets held sale
 219 2,797
 Assets held sale discontinued operations
 7,329

Assets held sale discontinued operations
 7,329
 TOTAL CURRENT
 36,545
 34,010
 EQUITY INVESTMENTS
 20,856
 16,260
 OTHER INVESTMENTS
 1,096
 989 OTHER ASSETS
 4,560
 4,248
 PROPERTY PLANT EQUIPMENT
 8,203
 10,635
 TRADEMARKS INDEFINITE LIVES
 6,729
 6,097
 BOTTLERS' FRANCHISE RIGHTS INDEFINITE LIVES
 138 3,676
 GOODWILL 9,401
 10,629
 OTHER 368 726
 TOTAL
 87,896
 $ 87,270
 LIABILITIES EQUITY
 CURRENT LIABILITIES
 Accounts payable accrued expenses
 8,748
 9,490
 Loans notes payable
 13,205
 12,498

9,490
 Loans notes payable
 13,205
 12,498
 maturities long-term debt
 3,298
 3,527
 Accrued income taxes
 410 307
 Liabilities held for sale
 37
 710
Liabilities sale discontinued operations
 1,496
 TOTAL CURRENT LIABILITIES
 27,194
 26,532
-TERM DEBT
 31,182
 29,684
 OTHER LIABILITIES
 4,081
 DEFERRED INCOME TAXES
 2,522
 3,753
 COCA COMPANY SHAREOWNERS' EQUITY
 Common stock $0. 25 par value Authorized 11,200 shares
 Issued 7,040 7,040 shares
 1,760
 Capital surplus
 15,864
 14,993
 Reinvested earnings

15,864
 14,993
 Reinvested earnings
 60,430
 65,502
 Accumulated comprehensive income (loss
 (10,305)
 (11,205)
 Treasury stock 2,781 2,752 shares
 (50,677)
 (47,988)
 EQUITY SHAREOWNERS COCA-COLA COMPANY
 17,072
 23,062
 EQUITY ATTRIBUTABLE NONCONTROLLING INTERESTS
 1,905
 158 TOTAL EQUITY
 18,977
 23,220
 TOTAL LIABILITIES EQUITY
 87,896
 87,270
 Notes Consolidated Financial Statements.
 74


| _id | dd2aeaa0a |
| title |  |
| text | Table of Contents
NETFLIX, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)

Year ended December 31,

2015

2014

2013
Revenues
 $
6,779,511 $
5,504,656 $
4,374,562
Cost of revenues

4,591,476
3,752,760
3,117,203
Marketing

824,092
607,186
469,942
Technology and development

650,788
472,321
378,769
General and administrative

407,329
269,741
180,301
Operating income

305,826
402,648
228,347
Other income (expense):

Interest expense

(132,716)

Interest expense

(132,716)
(50,219)
(29,142)
Interest and other income (expense)

(31,225)
(3,060)
(3,002)
Loss on extinguishment of debt

(25,129)
Income before income taxes

141,885
349,369
171,074
Provision for income taxes

19,244
82,570
58,671
Net income
 $
122,641 $
266,799 $
112,403
Earnings per share:

Basic
 $
0.29 $
0.63 $
0.28
Diluted
 $
0.28 $
0.62 $
0.26
Weighted-average common shares outstanding:

Basic

425,889
420,544
407,385
Diluted

436,456
431,894

420,544
407,385
Diluted

436,456
431,894
425,327
See accompanying notes to consolidated financial statements.
38

Table Contents
.
 CONSOLIDATED STATEMENTS OPERATIONS
 thousands share data
 ended December 31,
 2015
 2014
 2013
 Revenues
 $ 6,779,511 $
 5,504,656 $
 4,374,562
 Cost revenues
 4,591,476
 3,752,760
 3,117,203
 Marketing 824,092
 607,186
 469,942
 Technology development
 650,788
,321
 378,769
 General administrative
 407,329
 269,741
 180,301
 Operating income
 305,826
 402,648
 228,347
 Other income (expense):
 Interest expense
 (132,716)
 (50,219)
 (29,142)
 Interest income (expense
 (31,225)
 (3,060)

Interest income (expense
 (31,225)
 (3,060)
 (3,002)
 Loss extinguishment debt
 (25,129)
 Income before income taxes
 141,885
,369
 171,074
 Provision income taxes
 19,244
 82,570
 58,671
 Net income
 $ 122,641 $
 266,799 $
 112,403
 Earnings per share
 0. 29 $
. 63 $
. 28
 Diluted
 $. 28 $
. 62 $
.
 Weighted-average common shares
 425,889
 420,544
 407,385
 Diluted,456
 431,894
 425,327
 accompanying notes consolidated financial statements.
 38


| _id | dd2ad2676 |
| title |  |
| text | Consolidated Balance Sheets
Corning Incorporated and Subsidiary Companies

December 31,

(in millions, except share and per share amounts)

2022

2021

Assets

Current assets:

Cash and cash equivalents
 $
1,671 $
2,148
Trade accounts receivable, net of doubtful accounts - $40 and $42

1,721
2,004
Inventories (Note 5)

2,904
2,481
Other current assets (Notes 10 and 14)

1,157
1,026
Total current assets

7,453
7,659

Total current assets

7,453
7,659

Property, plant and equipment, net of accumulated depreciation - $14,147 and $13,969 (Note 8)

15,371
15,804
Goodwill, net (Note 9)

2,394
2,421
Other intangible assets, net (Note 9)

1,029
1,148
Deferred income taxes (Note 7)

1,073
1,066
Other assets (Notes 10 and 14)

2,179
2,056

Total Assets
 $
29,499 $
30,154

Liabilities and Equity

Current liabilities:

Current liabilities:

Current portion of long-term debt and short-term borrowings (Note 11)
 $
224 $
55
Accounts payable

1,804
1,612
Other accrued liabilities (Notes 10 and 13)

3,147
3,139
Total current liabilities

5,175
4,806

Long-term debt (Note 11)

6,687
6,989
Postretirement benefits other than pensions (Note 12)

407
622
Other liabilities (Notes 10 and 13)

4,955
5,192
Total liabilities

17,224
17,609

Consolidated Balance Sheets
 Corning Incorporated Subsidiary Companies
 December 31,
 millions except share share amounts
 2022
 2021
 Assets
 Current assets
 Cash cash equivalents
 $ 1,671 $
 2,148
 Trade accounts receivable doubtful $40 $42
 1,721
 2,004
 Inventories (Note 5)
 2,904
 2,481
 Other current assets (Notes 10 14)
 1,157
 1,026
 Total current assets
 7,453
 7,659
 Property plant equipment accumulated depreciation $14,147 $13,969 (Note 8)
 15,371
 15,804
 Goodwill net (Note 9)
 2,394
 2,421

15,804
 Goodwill net (Note 9)
 2,394
 2,421
 Other intangible assets (Note 9)
 1,029
 1,148
 Deferred income taxes (Note 7)
 1,073
 1,066
 Other assets (Notes 10 14)
 2,179
 2,056
 Total Assets
 $ 29,499 $
 30,154
 Liabilities Equity
 Current liabilities
 Current portion long debt short-term borrowings (Note 11)
 224 $
 55 Accounts payable
 1,804
 1,612
 Other accrued liabilities (Notes 10 13)
 3,147
 3,139
 Total current liabilities
 5,175
 Long-term debt (Note 11)
 6,687
 6,989

5,175
 Long-term debt (Note 11)
 6,687
 6,989
 Postretirement benefits pensions (Note 12)
 407 Other liabilities (Notes 10 13)
 4,955
 5,192
 Total liabilities
 17,224
 17,609


| _id | dd2ac1a1a |
| title |  |
| text | Twelve Months Ended June 30, 2022
Twelve Months Ended June 30, 2023
($ million)
EBITDA
EBIT
Net
Income
EPS
(Diluted
US
cents)(1)
EBITDA
EBIT
Net
Income
EPS
(Diluted
US
cents)(1)
Net income attributable to Amcor

805

805

805

52.9

1,048

1,048

1,048

70.5
Net income attributable to non-controlling
interests

10

10

10

10
Tax expense

300

300

193

193
Interest expense, net

135

135

259

259
Depreciation and amortization

579

569

259
Depreciation and amortization

579

569
EBITDA, EBIT, Net income and EPS

1,829

1,250

805

52.9

2,080

1,510

1,048

70.5
2019 Bemis Integration Plan

37

37

37

2.5

Net loss on disposals(2)

10

10

10

0.7

Impact of hyperinflation

16

16

16

1.0

24

24

24

1.9
Property and other losses, net(3)

13

13

13

0.8

2

2

2

0.1
Russia-Ukraine conflict impacts(4)

200

200

200

13.2

200

200

200

13.2

(90)
(90)
(90)
(6.0)
Pension settlements

8

8

8

0.5

5

5

5

0.3
Other

4

4

4

0.3

(3)
(3)
(3)
(0.3)
Amortization of acquired intangibles (5)

163

163

10.7

160

160

10.8
Tax effect of above items

(32)
(2.1)

(57)
(4.0)
Adjusted EBITDA, EBIT, Net income and EPS

2,117

1,701

1,224

80.5

2,018

1,608

1,089

73.3

Twelve Months Ended June 30, 2022
 Months Ended June 30, 2023
 ($ million)
 EBITDA
 EBIT Net
 Income
 EPS
 (Diluted
 US
 cents)(1)
 EBITDA
 EBIT Net
 Income
 EPS
 (Diluted US
 cents)(1)
 Net income attributable Amcor
 52. 9
 1,048
 1,048
 1,048
 70. 5
 Net income non-controlling
 interests
 10
 10
 10 10 Tax expense
 300
 300
 193
 193
 Interest expense net
 135
 135
 259
 259
 Depreciation amortization
 EBITDA, EBIT, Net income EPS
 1,829
 1,250
 805
 52. 9
 2,080
 1,510
 1,048
 70. 5

1,250
 805
 52. 9
 2,080
 1,510
 1,048
 70. 5
 2019 Bemis Integration Plan
 37
 37
 37
 2. 5
 Net loss on disposals(2)
 10
 10
 10 0. 7
 Impact hyperinflation
 16
 16 16 1. 0
 24
 24 24 1. 9
 Property other losses net(3)
 13
 13
 13 0. 8
 2 2 2 0. 1
 Russia-Ukraine conflict impacts(4)
 200
 200
 200 13. 2
 (90)
 (90)
 (90) (6. 0)
 Pension settlements
 8 8 8 0. 5
 5 5 5 0. 3
 Other 4 4 4 0. 3
 (3) (3) (3). 3)
 Amortization acquired intangibles (5)
 163
 163
 10. 7
 160
 160
 10. 8
Tax effect items

163
 10. 7
 160
 160
 10. 8
Tax effect items
 (32) (2. 1)
 (57)
 (4. 0
 Adjusted EBITDA income EPS
 2,117
 1,701
 1,224
 80. 5
 2,018
 1,608
 1,089
 73. 3


| _id | dd2ad4624 |
| title |  |
| text | Consolidated Statements of Operations
For the Years Ended December 31,
In millions, except per share amounts
2022
2021
2020
Revenues:

Products
$
226,616 $
203,738 $
190,688
Premiums
85,330
76,132
69,364
Services
9,683
11,042
7,856
Net investment income
838
1,199
798
Total revenues
322,467
292,111
268,706
Operating costs:
Cost of products sold
196,892
175,803
163,981
Benefit costs
71,281
64,260
55,679
Opioid litigation charges
5,803

Loss on assets held for sale
2,533

Loss on assets held for sale
2,533

Store impairments

1,358

Goodwill impairment

431

Operating expenses
38,212
37,066
35,135
Total operating costs
314,721
278,918
254,795
Operating income
7,746
13,193
13,911
Interest expense
2,287
2,503
2,907
Loss on early extinguishment of debt

452
1,440
Other income
(169)
(182)
(206)
Income before income tax provision
5,628
10,420
9,770
Income tax provision
1,463
2,522
2,569
Income from continuing operations
4,165
7,898
7,201

4,165
7,898
7,201
Loss from discontinued operations, net of tax

(9)
Net income
4,165
7,898
7,192

Consolidated Statements Operations
 Years Ended December 31,
 millions share amounts
 2022
 2021
 2020
 Revenues
 Products 226,616
 203,738 $
 190,688
 Premiums
 85,330
 76,132
 69,364
 Services 9,683
 11,042
 Net investment income
 1,199
 Total revenues
 322,467
 292,111
 268,706
 Operating costs
 products sold
 196,892
 175,803
 163,981
 Benefit costs
 71,281
 64,260
 55,679
 charges
 Loss assets sale
 2,533
 impairments
 1,358
 Goodwill impairment
 431 Operating expenses
 38,212
 37,066
 35,135

431 Operating expenses
 38,212
 37,066
 35,135
 Total operating costs
 314,721
 278,918
 254,795
 Operating income
 7,746
 13,193
 13,911
 Interest expense
 2,287
 2,503
 2,907
 Loss early extinguishment debt
 452 1,440
 Other income
 (169) Income before income tax provision
 5,628 10,420
 9,770
 Income tax provision
 1,463
 2,522
 2,569
 Income continuing operations
 4,165
 7,898
 7,201
 Loss discontinued operations tax
 income
 4,165
 7,898
 7,192


| _id | dd2af432a |
| title |  |
| text | Table of Contents
Consolidated Statement of Cash Flows
PepsiCo, Inc. and Subsidiaries
Fiscal years ended December 31, 2022, December 25, 2021 and December 26, 2020
(in millions)
2022
2021
2020
Operating Activities
Net income
$
8,978 $
7,679 $
7,175
Depreciation and amortization
2,763
2,710
2,548
Gain associated with the Juice Transaction
(3,321)

Impairment and other charges
3,618

Operating lease right-of-use asset amortization
517
505
478
Share-based compensation expense
343
301
264

Share-based compensation expense
343
301
264
Restructuring and impairment charges
411
247
289
Cash payments for restructuring charges
(224)
(256)
(255)
Acquisition and divestiture-related charges
80
(4)
255
Cash payments for acquisition and divestiture-related charges
(46)
(176)
(131)
Pension and retiree medical plan expenses
419
123
408
Pension and retiree medical plan contributions
(384)
(785)
(562)
Deferred income taxes and other tax charges and credits
(873)
298
361

(873)
298
361
Tax expense related to the TCJ Act
86
190

Tax payments related to the TCJ Act
(309)
(309)
(78)
Change in assets and liabilities:
Accounts and notes receivable
(1,763)
(651)
(420)
Inventories
(1,142)
(582)
(516)
Prepaid expenses and other current assets
118
159
26
Accounts payable and other current liabilities
1,842
1,762
766
Income taxes payable
57
30
(159)
Other, net
(359)
375
164
Net Cash Provided by Operating Activities
10,811
11,616
10,613
Investing Activities

10,811
11,616
10,613
Investing Activities
Capital spending
(5,207)
(4,625)
(4,240)
Sales of property, plant and equipment
251
166
55
Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of
intangible and other assets
(873)
(61)
(6,372)
Proceeds associated with the Juice Transaction
3,456

Other divestitures, sales of investments in noncontrolled affiliates and other assets
49
169
6
Short-term investments, by original maturity:

6
Short-term investments, by original maturity:
More than three months - purchases
(291)

(1,135)
More than three months - maturities
150
1,135

Three months or less, net
24
(58)
27
Other investing, net
11
5
40
Net Cash Used for Investing Activities
(2,430)
(3,269)
(11,619)
(Continued on following page)
62

Table Contents
 Consolidated Statement Cash Flows
 PepsiCo. Subsidiaries
 Fiscal years December 31, 2022 25 2021 26, 2020
 millions
 2021 Operating Activities
 Net income
 $
 7,679 $
 7,175
 Depreciation amortization
 2,763
 2,710
 2,548
 Gain Juice Transaction
 (3,321)
 Impairment charges
 3,618
 Operating lease right-of-use amortization
 517
 505
 Share-based compensation expense
 343
 301
 264
 Restructuring impairment charges
 411
 247
 289
 Cash payments restructuring charges
 (224)
 (256)
 (255)

(224)
 (256)
 (255)
 Acquisition divestiture-related charges
 80
 255
 Cash payments divestiture-related charges
 (46)
 (176)
 (131)
 Pension retiree medical plan expenses
 419
 123
 408
 Pension retiree medical plan contributions
 (384)
 (785)
 (562)
 Deferred income taxes tax charges credits
 (873)
 361
 Tax expense TCJ Act
 86
 190
 Tax payments TCJ Act
 (309)
 (309)
 (78)
 Change assets liabilities
 Accounts notes receivable
 (1,763)
 (651)
 (420)
 Inventories
 (1,142)
 (582)
 (516)

(651)
 (420)
 Inventories
 (1,142)
 (582)
 (516)
 Prepaid expenses current assets
 118
 159
 26 Accounts payable current liabilities
 1,842
 1,762
 766
 Income taxes payable
 57
 30
 (159)
 (359)
 375
 164 Cash Operating Activities
 10,811
 11,616
 10,613
 Investing Activities
 Capital spending
 (5,207)
 (4,625)
 (4,240)
 Sales property plant equipment
 251
 166
 55
Acquisitions net cash acquired investments noncontrolled affiliates purchases
 intangible other assets
 (873)
 (61)
 (6,372)

intangible other assets
 (873)
 (61)
 (6,372)
 Proceeds associated Juice Transaction
 3,456
 Other divestitures sales investments noncontrolled affiliates assets
 49
 169
 6
 Short-term investments original maturity
 three months purchases
 (291)
 (1,135)
 three months maturities
 150
 1,135
 Three months less net
 24
 (58)
 27
 Other investing net
 11
 5
 40
 Net Cash Used Investing Activities
 (2,430)
 (3,269)
 (11,619)
 (Continued following page)
 62


| _id | dd2abf4f4 |
| title |  |
| text | Consolidated Balance Sheets
December 31, 2022 and 2021
2022
2021
(in millions, except share and per share data)
ASSETS
CURRENT ASSETS
Cash and cash equivalents
$
1,374
$
943
Restricted cash
536
304
Short-term investments
730
232
Accounts receivable, net of allowance for doubtful accounts of $5 and $5, respectively
1,799
1,418
Inventory
1,055
604

Consolidated Balance Sheets
 December 31, 2022 2021
 2022
 (in millions except share share data)
 ASSETS
 CURRENT
 Cash equivalents
 $
 1,374
 $
 943
 Restricted cash
 536
 304
 Short-term investments
 730
 232
 Accounts receivable allowance doubtful accounts $5 $5
 1,799
 1,418
 Inventory
 1,055


| _id | dd2b059ae |
| title |  |
| text | Share Repurchase Program
During the fourth quarter of fiscal 2022, the Company repurchased 722,457 shares of its
common stock at a cost of $328.1 million. During fiscal 2022, the Company repurchased 2.2
million shares of its common stock at a cost of $900.0 million. As of January 28, 2023, $1.1
billion remained available under the $2.0 billion share repurchase program announced in
March 2022.

Share Repurchase Program
 fourth quarter of fiscal 2022 Company repurchased 722,457 shares
 common stock cost $328. 1 million. During fiscal 2022, Company repurchased 2. 2
 million shares common stock cost $900. 0 million. As of January 28, 2023, $1. 1
 billion remained available under $2. 0 billion share repurchase program announced
 March 2022.


| _id | dd2af18f0 |
| title |  |
| text | Forward-Looking Statements
This Annual Report on Form 10-K contains statements reflecting our views about our future performance that constitute
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (Reform Act).
Statements that constitute forward-looking statements within the meaning of the Reform Act are generally identified through the
inclusion of words such as aim, anticipate, believe, drive, estimate, expect, expressed confidence, forecast,

future, goal, guidance, intend, may, objective, outlook, plan, position, potential, project, seek,
should, strategy, target, will or similar statements or variations of such words and other similar expressions. All
statements addressing our future operating performance, and statements addressing events and developments that we expect or
anticipate will occur in the future, are forward-looking statements within the meaning of the Reform Act. These forward-looking

statements are based on currently available information, operating plans and projections about future events and trends. They
inherently involve risks and uncertainties that could cause actual results to differ materially from those predicted in any such
forward-looking statement. These risks and uncertainties include, but are not limited to, those described in Item 1A. Risk
Factors and Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations Our Business

Our Business Risks. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak
only as of the date they are made. We undertake no obligation to update any forward-looking statement, whether as a result of
new information, future events or otherwise. The discussion of risks in this report is by no means all-inclusive but is designed to
highlight what we believe are important factors to consider when evaluating our future performance.
PART I
Item 1. Business.

PART I
Item 1. Business.
When used in this report, the terms we, us, our, PepsiCo and the Company mean PepsiCo, Inc. and its consolidated
subsidiaries, collectively. Certain terms used in this Annual Report on Form 10-K are defined in the Glossary included in Item 7.
of this report.
Company Overview
We were incorporated in Delaware in 1919 and reincorporated in North Carolina in 1986. We are a leading global beverage and

convenient food company with a complementary portfolio of brands, including Lays, Doritos, Cheetos, Gatorade, Pepsi-Cola,
Mountain Dew, Quaker and SodaStream. Through our operations, authorized bottlers, contract manufacturers and other third
parties, we make, market, distribute and sell a wide variety of beverages and convenient foods, serving customers and consumers
in more than 200 countries and territories.
Our Operations

Our Operations
We are organized into seven reportable segments (also referred to as divisions), as follows:
1) Frito-Lay North America (FLNA), which includes our branded convenient food businesses in the United States and
Canada;
2) Quaker Foods North America (QFNA), which includes our branded convenient food businesses, such as cereal, rice, pasta
and other branded food, in the United States and Canada;

3) PepsiCo Beverages North America (PBNA), which includes our beverage businesses in the United States and Canada;
4) Latin America (LatAm), which includes all of our beverage and convenient food businesses in Latin America;
5) Europe, which includes all of our beverage and convenient food businesses in Europe;

Forward-Looking Statements
 Annual Report on Form 10-K contains statements reflecting views about future performance
 forward-looking statements within meaning Private Securities Litigation Reform Act of 1995 (Reform Act).
 Statements forward-looking statements within Reform Act are identified through
 inclusion of words as aim, anticipate, believe, drive, estimate, expect, expressed confidence, forecast,
 future, goal, guidance, intend, may, objective, outlook, plan, position, potential, project, seek,

should strategy, target, will or similar statements or variations words expressions. All
 statements addressing future operating performance, and statements addressing events and developments we expect or
 anticipate occur in future, are forward-looking statements within Reform Act. forward-looking
 statements are based on available information, operating plans projections about future events trends.
 involve risks and uncertainties that could cause actual results to differ from predicted in

forward-looking statement. risks and uncertainties include not limited to those described in Item 1A. Risk
 Factors and Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations Our Business
 Business Risks. Investors cautioned not to place undue reliance on such forward-looking statements, speak
 only as of date they made. We undertake no obligation to update forward-looking statement

new information future events or. discussion of risks in report is no all-inclusive but designed to
 highlight important factors to consider when evaluating future performance.
 PART I
 Item 1. Business.
 used in report terms we, us, our, PepsiCo and the Company mean PepsiCo, Inc. and its consolidated
 subsidiaries, collectively. Certain terms used in Annual Report on Form 10-K are defined in Glossary in Item 7.
 of this report.
 Company Overview

of this report.
 Company Overview
 incorporated in Delaware 1919 reincorporated North Carolina 1986. leading global beverage and
 convenient food company with complementary portfolio of brands including Lays, Doritos, Cheetos, Gatorade Pepsi-Cola,
 Mountain Dew Quaker SodaStream. Through our operations, authorized bottlers, contract manufacturers third
 parties, we make, market distribute sell wide variety of beverages convenient foods serving customers consumers

in more than 200 countries and territories.
 Operations
 organized into seven reportable segments (also referred divisions),:
 1) Frito-Lay North America (FLNA), includes branded convenient food businesses in United States
 Canada;
 2) Quaker Foods North America (QFNA), includes branded convenient food businesses cereal, rice, pasta
 other branded food in United States Canada;
 3) PepsiCo Beverages North America (PBNA), includes beverage businesses in United States and Canada;

4) Latin America (LatAm), includes all beverage and convenient food businesses in Latin America;
 5) Europe, includes all beverage and convenient food businesses in Europe;


| _id | dd2ae3dfe |
| title |  |
| text | MGM RESORTS INTERNATIONAL AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)

Year Ended December 31,

2020

2019

2018

Revenues

Casino
$
2,871,720
$
6,517,759
$
5,753,150
Rooms

830,382

2,322,579

2,212,573
Foodandbeverage

696,040

2,145,247

1,959,021
Entertainment,retailandother

518,991

1,477,200

1,412,860
Reimbursedcosts

244,949

436,887

425,492

5,162,082

12,899,672

11,763,096
Expenses

Casino

1,701,783

3,623,899

Casino

1,701,783

3,623,899

3,199,775
Rooms

419,156

829,677

791,761
Foodandbeverage

674,118

1,661,626

1,501,868
Entertainment,retailandother

412,705

1,051,400

999,979
Reimbursedcosts

244,949

436,887

425,492
Generalandadministrative

2,122,333

2,101,217

1,764,638
Corporateexpense

460,148

464,642

419,204
Preopeningandstart-upexpenses

84

7,175

151,392
Propertytransactions,net

93,567

275,802

9,147
GainonREITtransactions,net

(1,491,945)

(2,677,996)

Depreciationandamortization

(2,677,996)

Depreciationandamortization

1,210,556

1,304,649

1,178,044

5,847,454

9,078,978

10,441,300
Income from unconsolidated affiliates

42,938

119,521

147,690
Operating income (loss)

(642,434)

3,940,215

1,469,486
Non-operating income (expense)

Interestexpense,netofamountscapitalized

(676,380)

(847,932)

(769,513)
Non-operatingitemsfromunconsolidatedaffiliates

(103,304)

(62,296)

(47,827)
Other,net

(89,361)

(183,262)

(18,140)

(869,045)

(1,093,490)

(183,262)

(18,140)

(869,045)

(1,093,490)

(835,480)
Income (loss) before income taxes

(1,511,479)

2,846,725

634,006
Benefit(provision)forincometaxes

191,572

(632,345)

(50,112)
Net income (loss)

(1,319,907)

2,214,380

583,894
Less:Net(income)lossattributabletononcontrollinginterests

287,183

(165,234)

(117,122)
Net income (loss) attributable to MGM Resorts International
$
(1,032,724)
$
2,049,146
$
466,772

Earnings (loss) per share

Earnings (loss) per share

Basic
$
(2.02)
$
3.90
$
0.82
Diluted
$
(2.02)
$
3.88
$
0.81
Weighted average common shares outstanding

Basic

494,152

524,173

544,253
Diluted

494,152

527,645

549,536

The accompanying notes are an integral part of these consolidated financial statements.

63

MGM RESORTS INTERNATIONAL SUBSIDIARIES
 CONSOLIDATED STATEMENTS OPERATIONS
 thousands except share data) Year Ended December 31, 2020 2019 2018 Revenues Casino $ 2,871,720
 $ 6,517,759
 $,150
 Rooms 830,382
 2,322,579
 2,212,573
 Foodandbeverage 696,040
 2,145,247
 1,959,021
 Entertainment,retailandother 518,991
 1,477,200
 1,412,860
 Reimbursedcosts 244,949
,887
 425,492
 5,162,082
 12,899,672
 11,763,096
 Expenses Casino 1,701,783
 3,623,899
 3,199,775
 Rooms 419,156
 829,677
 791,761

3,199,775
 Rooms 419,156
 829,677
 791,761
 Foodandbeverage 674,118
 1,661,626
 1,501,868
 Entertainment,retailandother 412,705
 1,051,400
 999,979
 Reimbursedcosts 244,949
,887
 425,492
 Generalandadministrative 2,122,333
 2,101,217
 1,764,638
 Corporateexpense 460,148
,642
 419,204
 Preopeningandstart-upexpenses 84 7,175 151,392
 Propertytransactions,net
 93,567
 275,802
 9,147
 GainonREITtransactions,net (1,491,945)
 (2,677,996)
 Depreciationandamortization 1,210,556
 1,304,649
 1,178,044
,454

1,304,649
 1,178,044
,454
 9,078,978
 10,441,300
 Income unconsolidated affiliates
 42,938
119,521
 147,690
 Operating income (loss)
 (642,434)
,215
 1,469,486
 Non-operating income (expense)
 Interestexpense,netofamountscapitalized (676,380)
 (847,932)
 (769,513)
 Non-operatingitemsfromunconsolidatedaffiliates
 (103,304)
 (62,296)
 (47,827)
 (89,361)
 (183,262)
 (18,140)
 (869,045)
 (1,093,490)
 (835,480)
 Income (loss) before income taxes
 (1,511,479)
 2,846,725
,006
 Benefit(provision)forincometaxes

2,846,725
,006
 Benefit(provision)forincometaxes
 191,572
 (632,345)
 (50,112)
 Net income (loss)
 (1,319,907)
 2,214,380
 583,894
 Less:Net(income)lossattributabletononcontrollinginterests
 287,183
 (165,234)
 (117,122)
 Net income (loss) attributable MGM Resorts International
 (1,032,724)
 2,049,146
 466,772
 Earnings (loss) per share
 $ (2. 02)
 3. 90
 $ 0. 82
 Diluted
 $ (2. 02)
 3. 88
 $. 81
 Weighted average common shares
 494,152
 524,173
 544,253
 Diluted,152
 527,645
,536

524,173
 544,253
 Diluted,152
 527,645
,536
 accompanying notes integral part of consolidated financial statements.
 63


| _id | dd2b01854 |
| title |  |
| text | UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-K
 Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the fiscal year ended January 28, 2023
or
 Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from _____________ to _____________
Commission File Number: 001-33764
ULTA BEAUTY, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of

Delaware
(State or other jurisdiction of
incorporation or organization)
38-4022268
(I.R.S. Employer
Identification No.)
1000 Remington Blvd., Suite 120
Bolingbrook, Illinois
(Address of principal executive offices)
60440
(Zip code)
Registrants telephone number, including area code: (630) 410-4800
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol
Name of each exchange on which registered
Common stock, par value $0.01 per share
ULTA
The NASDAQ Global Select Market

ULTA
The NASDAQ Global Select Market
Securities registered pursuant to Section 12(g) of the Act: None

UNITED STATES
 SECURITIES EXCHANGE COMMISSION
 Washington, DC 20549
 FORM 10-K
 Annual Report Section 13 or 15(d) Securities Exchange Act of 1934
 fiscal year ended January 28, 2023
 Transition Report Section 13 or 15(d) Securities Exchange Act 1934
 transition period from _____________ to _____________
 Commission File Number: 001-33764
 ULTA BEAUTY, INC.
 (Exact name registrant specified charter)
 Delaware
 (State or jurisdiction
 incorporation organization)
 38-4022268
 (I. R. S. Employer

38-4022268
 (I. R. S. Employer
 Identification No. )
 1000 Remington Blvd. Suite 120
 Bolingbrook, Illinois
 (Address principal executive offices)
 60440
 (Zip code)
 Registrants telephone number area code: (630) 410-4800
 Securities registered Section 12(b) Act:
 Title each class
 Trading symbol
 Name of each exchange registered
 Common stock par value $0. 01 per share
 ULTA
 NASDAQ Global Select Market
 Securities registered Section 12(g) Act: None


| _id | dd2acffb6 |
| title |  |
| text | The Boeing Company and Subsidiaries
Consolidated Statements of Operations
(Dollars in millions, except per share data)

Years ended December 31,
2022
2021
2020
Sales of products
$55,893
$51,386
$47,142
Sales of services
10,715
10,900
11,016
Total revenues
66,608
62,286
58,158
Cost of products
(53,969)
(49,954)
(54,568)
Cost of services
(9,109)
(9,283)
(9,232)
Boeing Capital interest expense
(28)
(32)
(43)
Total costs and expenses
(63,106)
(59,269)
(63,843)
3,502
3,017
(5,685)

(63,106)
(59,269)
(63,843)
3,502
3,017
(5,685)
(Loss)/income from operating investments, net
(16)
210
9
General and administrative expense
(4,187)
(4,157)
(4,817)
Research and development expense, net
(2,852)
(2,249)
(2,476)
Gain on dispositions, net
6
277
202
Loss from operations
(3,547)
(2,902)
(12,767)
Other income, net
1,058
551
447
Interest and debt expense
(2,533)
(2,682)
(2,156)
Loss before income taxes
(5,022)
(5,033)
(14,476)
Income tax (expense)/benefit
(31)
743
2,535

Boeing Company Subsidiaries
 Consolidated Statements Operations
 millions share data
 ended December 31,
 2022
 2021
 Sales products
 $55,893
 $51,386
 $47,142
 Sales services
 10,715
 10,900
 11,016
 Total revenues
 66,608
 62,286
 58,158
 Cost products
 (53,969)
 (49,954)
 (54,568)
 services
 (9,109)
 (9,283)
 (9,232)
 Boeing Capital interest expense
 (28) Total costs expenses
 (63,106)
 (59,269)
 (63,843)
 3,502
 (5,685)
 (Loss)/income operating investments
 General administrative expense
 (4,187)

General administrative expense
 (4,187)
 (4,157)
 (4,817)
 Research development expense
 (2,852)
 (2,249)
 (2,476)
 Gain dispositions
 6 277
 Loss operations
 (3,547)
 (2,902)
 (12,767)
 Other income net
 1,058
 447 Interest debt expense
 (2,533)
 (2,682)
 (2,156)
 Loss before income taxes
 (5,022)
 (5,033)
 (14,476)
 Income tax (expense/benefit
 (31) 743
 2,535